Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Bas Groot Koerkamp

ResearcherPublications, citations & collaboration network

Bas Groot Koerkamp is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 1,036 works, 29,556 citations, an h-index of 82 and an i10-index of 388.

1,036
Works
29,556
Citations
82
h-index
388
i10-index

How has Bas Groot Koerkamp's publication output changed over time?

ScholarIQpublication output · 2016–2025

Output grew0% over the shown period — from 1 works in 2016 to 1 in 2025.

1
1
2
4
2
1
1
2016201720182019202020222025

What are the most-cited papers on Bas Groot Koerkamp?

ScholarIQmost cited works
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesús M. Bañales, José J.G. Marı́n, Ángela Lamarca, Pedro M. Rodrigues, Shahid A. Khan, Lewis R. Roberts, Vincenzo Cardinale, Guido Carpino, Jesper B. Andersen, Chiara Braconi, Diego F. Calvisi, María J. Perugorria, Luca Fabris, Luke Boulter, Rocı́o I.R. Macı́as, Eugenio Gaudio, Domenico Alvaro, Sergio A. Gradilone, Mario Strazzabosco, Marco Marzioni, Cédric Coulouarn, Laura Fouassier, Chiara Raggi, Pietro Invernizzi, Joachim C. Mertens, Anja Moncsek, Sumera I. Ilyas, Julie K. Heimbach, Bas Groot Koerkamp, Jordi Bruix, Alejandro Forner, John Bridgewater, Juan W. Valle, Gregory J. Gores
S120397320. 20202,520 CitationsOPEN ACCESS
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
Eva Versteijne, Mustafa Suker, Karin Groothuis, Janine M. Akkermans-Vogelaar, Marc G. Besselink, Bert A. Bonsing, Jeroen Buijsen, Olivier R. Busch, Geert-Jan Creemers, Ronald M. van Dam, Ferry A.L.M. Eskens, Sebastiaan Festen, Jan Willem B. de Groot, Bas Groot Koerkamp, Ignace H. J. T. de Hingh, Marjolein Y.V. Homs, Jeanin E. van Hooft, Emile D. Kerver, Saskia Luelmo, Karen J. Neelis, Joost J. Nuyttens, Gabriel Paardekooper, Gijs A. Patijn, Maurice J.C. van der Sangen, Judith de Vos‐Geelen, Johanna W. Wilmink, Aeilko H. Zwinderman, Cornelis J.A. Punt, Casper H.J. van Eijck, Geertjan van Tienhoven, for the Dutch Pancreatic Cancer Group
Journal of Clinical Oncology. 20201,088 CitationsOPEN ACCESS
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
Mustafa Suker, Berend R. Beumer, Eran Sadot, Lysiane Marthey, Jason E. Faris, Eric A. Mellon, Bassel F. El‐Rayes, Andrea Wang‐Gillam, Jill Lacy, Peter J. Hosein, Sing Yu Moorcraft, Thierry Conroy, Florian Hohla, Peter J. Allen, Julien Taı̈eb, Theodore S. Hong, Ravi Shridhar, Ian Chau, Casper H.J. van Eijck, Bas Groot Koerkamp
The Lancet Oncology. 2016927 CitationsOPEN ACCESS
Minimally Invasive Versus Open Distal Pancreatectomy (LEOPARD)
Thijs de Rooij, Jony van Hilst, Hjalmar van Santvoort, Djamila Boerma, P. van den Boezem, Freek Daams, Ronald M. van Dam, C. Dejong, Eino van Duyn, Marcel G. W. Dijkgraaf, Casper H.J. van Eijck, Sebastiaan Festen, Michael F. Gerhards, Bas Groot Koerkamp, Ignace H. J. T. de Hingh, Geert Kazemier, Joost M. Klaase, Ruben H. de Kleine, C. van Laarhoven, Misha Luyer, Gijs A. Patijn, Pascal Steenvoorde, Mustafa Suker, Moh’d Abu Hilal, Olivier R. Busch, Marc G. Besselink
Annals of Surgery. 2018618 CitationsOPEN ACCESS
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial
Jony van Hilst, Thijs de Rooij, Koop Bosscha, David J. Brinkman, Susan van Dieren, Marcel G Dijkgraaf, Michael F. Gerhards, Ignace H. J. T. de Hingh, Tom M Karsten, Daniel J. Lips, Misha Luyer, Olivier R Busch, Sebastiaan Festen, Marc G Besselink, Marc G Besselink, Jony van Hilst, Thijs de Rooij, Koop Bosscha, David J. Brinkman, Susan Van Dieren, Marcel G. W. Dijkgraaf, Michael F Gerhards, Ignace H De Hingh, Tom M. Karsten, Daniel J Lips, Misha D Luyer, Olivier R. Busch, Sebastiaan Festen, Marc G Besselink, Marc G Besselink, Hendrik A. Marsman, Thomas M. van Gulik, Dennis A. Wicherts, Wietse J. Eshuis, Luna A. Stibbe, Els J. Nieveen van Dijkum, Janine E Van Hooft, Paul Fockens, Hanneke W.M. van Laarhoven, Johanna W. Wilmink, Marcel J Van de Vijver, Maarten F. Bijlsma, Joanne Verheij, C. Yung Nio, Krijn P. van Lienden, Geertjan van Tienhoven, Annuska Schoorlemmer, Geert-Jan Creemers, Casper HJ van Eijck, Bas Groot Koerkamp, Marco J. Bruno, Ferry A.L.M. Eskens, Joost J. Nuyttens, Chulja J. Pek, George P. van der Schelling, Tom Seerden, Gijs A. Patijn, Vincent B. Nieuwenhuijs, Jan Willem de Groot, Bert A. Bonsing, Alexander L. Vahrmeijer, Rutger‐Jan Swijnenburg, J. Sven D. Mieog, Erwin van der Harst, Marcel den Dulk, Steven W.M. Olde Damink, C. Dejong, Ronald M. van Dam, Judith MPGM De Vos, Mike S.L. Liem, Cees J. van Laarhoven, Harry van Goor, Peter B. van den Boezem, B.M. van der Kolk, Martijn W.J. Stommel, John J. Hermans, Erwin JM van Geenen, Sandra A. Radema, Lodewijk A.A. Brosens, Joris J. Scheepers, Daphne Roos, Djamilla Boerma, Wouter te Riele, Hjalmar C. van Santvoort, Thomas L. Bollen, Fanny Wit, I. Quintus Molenaar, Nadia Haj Mohammad, Maarten S. van Leeuwen, Annemarie Roele, Kees P De Jong, Vincent E. de Meijer, Joost M. Klaase, Geert Kazemier, Babs M. Zonderhuis, Freek Daams, Martijn R. Meijerink, Anouk E.J. Latenstein, L. Bengt van Rijssen, Carolijn L. Nota
˜The œLancet. Gastroenterology & hepatology. 2019604 CitationsOPEN ACCESS

Related on ScholarIQ

Erasmus MC
Institution
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Paper
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
Paper
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
Paper
Minimally Invasive Versus Open Distal Pancreatectomy (LEOPARD)
Paper
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial
Paper
470M+ articles · free account